J7626 HCPCS code: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

J7626 is the HCPCS Level II code for budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg. In 2024 Medicare paid an average of $0.81 per service for J7626 across 1,837 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 186 per day on DME suppliers. Medicare volume fell 28% from 2022 to 2024 (2,563 to 1,837 services). In 2024, 23,423 suppliers billed Medicare for J7626 (purchases), serving 100,754 beneficiaries; Texas, California, Florida accounted for 19% of services.

Code details

Who bills J7626 (2024)

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for J7626, 2022–2024

States with the most J7626 services (2024)

NCCI unit limits (MUE)

Medicare policy articles for this code

• A52466: Nebulizers - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance

Covered diagnoses (215 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

Showing 10 of 215. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for J7626

• 2002-01-01: J7626 added to HCPCS Level II
• Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01

Frequently asked questions

What is HCPCS code J7626?

J7626 is the HCPCS Level II code for budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg. Short descriptor: "Budesonide non-comp unit".

How much does Medicare pay for J7626?

In 2024, the average Medicare payment was $0.81 per service (average allowed $1.12).

Does Medicare cover J7626?

Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.

Which diagnoses support coverage for J7626?

Medicare policy articles that cite J7626 list 215 covered ICD-10-CM diagnosis codes across 1 article. The most cited include A15.0 (Tuberculosis of lung), A22.1 (Pulmonary anthrax), A37.01 (Whooping cough due to Bordetella pertussis with pneumonia). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of J7626 can be billed per day?

186 on DME suppliers; 2 on practitioner claims (NCCI medically unlikely edits).

Related J76 codes

• J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
• J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
• J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
• J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
• J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
• J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
• J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
• J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
• J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
• J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
• J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
• J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

• Run a reimbursement report for a device billed under J7626
• Watch J7626 for fee, coverage and descriptor changes
• Build a full Medicare revenue model for J7626

Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All J codes · HCPCS lookup